Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$883.2 - $1071.19 $61,824 - $74,983
-70 Reduced 6.63%
986 $1.04 Million
Q1 2024

May 15, 2024

SELL
$902.69 - $993.35 $55,064 - $60,594
-61 Reduced 5.46%
1,056 $1.02 Million
Q4 2023

Jan 30, 2024

BUY
$775.18 - $881.7 $247,282 - $281,262
319 Added 39.97%
1,117 $981,000
Q3 2023

Oct 23, 2023

SELL
$692.45 - $844.37 $4,847 - $5,910
-7 Reduced 0.87%
798 $656,000
Q2 2023

Jul 24, 2023

SELL
$700.03 - $830.35 $140,706 - $166,900
-201 Reduced 19.98%
805 $578,000
Q1 2023

May 12, 2023

SELL
$680.49 - $826.97 $39,468 - $47,964
-58 Reduced 5.45%
1,006 $826,000
Q4 2022

Feb 10, 2023

SELL
$705.89 - $766.39 $65,647 - $71,274
-93 Reduced 8.04%
1,064 $767,000
Q3 2022

Nov 09, 2022

BUY
$573.97 - $724.32 $294,446 - $371,576
513 Added 79.66%
1,157 $797,000
Q2 2022

Aug 16, 2022

SELL
$548.35 - $738.84 $201,244 - $271,154
-367 Reduced 36.3%
644 $381,000
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $286,847 - $336,643
482 Added 91.12%
1,011 $706,000
Q4 2021

Feb 15, 2022

SELL
$543.48 - $670.97 $79,891 - $98,632
-147 Reduced 21.75%
529 $334,000
Q3 2021

Nov 09, 2021

BUY
$574.03 - $680.96 $85,530 - $101,463
149 Added 28.27%
676 $409,000
Q2 2021

Aug 13, 2021

BUY
$472.8 - $558.54 $4,255 - $5,026
9 Added 1.74%
527 $295,000
Q1 2021

May 11, 2021

SELL
$446.73 - $548.2 $290,821 - $356,878
-651 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$478.3 - $607.98 $42,090 - $53,502
88 Added 15.63%
651 $314,000
Q3 2020

Nov 10, 2020

SELL
$544.75 - $658.21 $41,945 - $50,682
-77 Reduced 12.03%
563 $316,000
Q2 2020

Aug 05, 2020

BUY
$493.32 - $643.92 $95,210 - $124,276
193 Added 43.18%
640 $399,000
Q1 2020

May 11, 2020

BUY
$336.18 - $494.43 $150,272 - $221,010
447 New
447 $218,000
Q4 2017

Feb 13, 2018

SELL
$358.63 - $469.95 $325,277 - $426,244
-907 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$431.38 - $504.0 $391,261 - $457,128
907
907 $405,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.